Perfil de la empresa · Healthcare

Bachem Holding AG

BANB · SW
País / Región
Switzerland
Empleados
2130
Buffett Score
59/100
Media
Capitalización5402,85 M CHF
Ingresos (TTM)695,07 M CHF
EBITDA210,76 M CHF
Margen neto21,41 %
ROE10,44 %
PER (TTM)36,41
PER previsto29,85
PEG0,61
BPA1,98 CHF
Rentabilidad por dividendo1,24 %
Rango de 52 semanas48,22 CHF – 83,25 CHF

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.